title: Midterm outcomes of percutaneous transluminal septal myocardial ablation in patients with hypertrophic obstructive cardiomyopathy refractory to medication.
authors.affiliation: Cardiological Division, Nanjing First Hospital of Nanjing Medical University, Nanjing 210006, China. chmengx@126.com
authors.forename: Shao-liang
authors.initials: SL
authors.lastname: Chen
authors.forename: Fei
authors.initials: F
authors.lastname: Ye
authors.forename: Zu-ling
authors.initials: ZL
authors.lastname: Xu
authors.forename: Song
authors.initials: S
authors.lastname: Lin
authors.forename: Bao-xiang
authors.initials: BX
authors.lastname: Duan
authors.forename: Zhen-ling
authors.initials: ZL
authors.lastname: Dai
authors.forename: Shou-jie
authors.initials: SJ
authors.lastname: Shan
authors.forename: Jun-jie
authors.initials: JJ
authors.lastname: Zhang
mesh_terms: D000328:Adult; D000368:Aged; D002037:Bundle-Branch Block / Q000209:etiology; D002312:Cardiomyopathy, Hypertrophic / Q000601:surgery*; D017115:Catheter Ablation / Q000009:adverse effects / Q000379:methods*; D005260:Female; D006346:Heart Septum / Q000601:surgery*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000209:etiology